StonvexLoading…
StonvexStonvexStonvexCore line items from NHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $369.81M | $1.47B | $1.10B | $724.96M |
Operating Income | $32.25M | $128.35M | $95.23M | $64.86M |
Net Income | $35.86M | $120.02M | $95.17M | $55.93M |
EPS (Diluted) | $2.27 | $7.67 | $6.10 | $3.59 |
Total Assets | $1.52B | $1.53B | $1.57B | $1.56B |
Total Liabilities | $427.48M | $451.90M | $513.91M | $536.84M |
Cash & Equivalents | $85.53M | $92.83M | $130.63M | $110.99M |
Free Cash Flow OCF − CapEx | $52.89M | $148.63M | $142.22M | $85.73M |
Shares Outstanding | 15.61M | 15.54M | 15.52M | 15.50M |